Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial
Top Cited Papers
Open Access
- 1 April 2006
- journal article
- clinical trial
- Published by Elsevier in The Lancet Neurology
- Vol. 5 (4) , 317-322
- https://doi.org/10.1016/s1474-4422(06)70383-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trialThe Lancet, 2005
- A new measure of prognostic separation in survival dataStatistics in Medicine, 2004
- Assessment and comparison of prognostic classification schemes for survival dataStatistics in Medicine, 1999
- Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsyNeurology, 1997
- Early Treatment of a Single Generalized Tonic-Clonic Seizure to Prevent RecurrenceArchives of Neurology, 1996
- Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic‐clonic seizureNeurology, 1993
- First seizure in adults: to treat or not to treatClinical Neurology and Neurosurgery, 1992
- The risk of seizure recurrence following a first unprovoked seizureNeurology, 1991
- A randomized study of carbamazepine versus no medication after a first unprovoked seizure in childhoodNeurology, 1989
- Remission of Seizures and Relapse in Patients with EpilepsyEpilepsia, 1979